Galapagos up 10% as Major Shareholder Intends to Talk About Strategy
Major Investor Says Galapagos Is 'Undervalued,' Plans To Push On Company's 'Performance' And 'Strategic Opportunities'
Galapagos NV Up Over 11%, on Pace for Largest Percent Increase Since January 2022 -- Data Talk
Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday
Express News | Galapagos Shares Are Trading Higher After Ecor1 Capital Reported a 9.9% Stake in the Company
Express News | Ecor1 Capital Reported A 9.9% Stake In Galapagos On Friday In A 13D Filing
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Sector Update: Health Care Stocks Rise Premarket Friday
Sector Update: Health Care
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday as Investors Hope for Dovish Powell Remarks
Galapagos (GLPG) Up on FDA Nod to Begin Phase I/II Lymphoma Study
FDA Clears Galapagos' IND Application For Phase 1/2 Study Of GLPG5101 In R/R Non-Hodgkin Lymphoma
Galapagos' Innovative Cancer Therapy Advances With FDA Approval
FMR LLC Adjusts Stake in Galapagos NV
Morgan Stanley Maintains Galapagos(GLPG.US) With Hold Rating, Maintains Target Price $32
Analysts Are Neutral on These Healthcare Stocks: Baxter International (BAX), Galapagos (GLPG)
Morgan Stanley Maintains Galapagos(GLPG.US) With Hold Rating, Cuts Target Price to $32
Galapagos (GLPG) Gets a Hold From Morgan Stanley
Express News | Galapagos NV : Raymond James Cuts to Market Perform From Outperform
Analysts Offer Insights on Healthcare Companies: Galapagos (GLPG), Oncolytics Biotech (ONCY) and Irhythm Technologies (IRTC)